Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter October 12, 2013

Cortisol and cortisone ratio in urine: LC-MS/MS method validation and preliminary clinical application

  • Giorgia Antonelli EMAIL logo , Carlo Artusi , Mariela Marinova , Laura Brugnolo , Martina Zaninotto , Carla Scaroni , Rosalba Gatti , Franco Mantero and Mario Plebani

Abstract

Background: The determination of urinary cortisol/cortisone ratio is of clinical utility in cases of Cushing’s syndrome, apparent mineralocorticoid excess, and also provides information on 11β-hydroxysteroid dehydrogenase (11β-HSD) type 2 activity. It is therefore of utmost importance to ensure accurate cortisol and cortisone measurement and establish appropriate reference ranges.

Methods: After the isotopic dilution of urine, sample cleanups were obtained with on-line solid-phase extraction and cortisol and cortisone, separated using a Zorbax Eclipse XDB-C18 HPLC analytical column, were analyzed by tandem mass spectrometry with an electrospray ionization source in positive ion mode operation.

Results: The method was linear, with concentrations of up to 625 and 1125 nmol/L and lower limit of quantitation (LLOQ) of 5 and 6 nmol/L, for cortisol and cortisone, respectively. Within-run and between-run coefficients of variation were <5% and 6% for cortisol and 6% and 8% for cortisone, respectively. No ion suppression was observed. The non-parametric reference range for the cortisol/cortisone ratio was 0.14–1.09.

Conclusions: A simple and sensitive liquid chromatography tandem mass spectrometry method was developed and validated for the measurement of cortisol and cortisone in urine. Our findings indicate that the proposed analytical method is suitable for routine purposes and useful in many pathological conditions.


Corresponding author: Giorgia Antonelli, U.O.C. of Laboratory Medicine, Department of Medicine, University of Padova, 35128 Padova, Italy, Phone: +39 0498212799, E-mail:

References

1. Reimondo G, Pia A, Bovio S, Allasino B, Daffara F, Paccotti P, et al. Laboratory differentiation of Cushing’s syndrome. Clin Chim Acta 2008;388:5–14.10.1016/j.cca.2007.10.036Search in Google Scholar PubMed

2. Remer T, Maser-Gluth C, Wudy SA. Glucocorticoid measurements in health and disease – metabolic implications and the potential of 24-h urine analyses. Mini Rev Med Chem 2008;8:153–70.10.2174/138955708783498096Search in Google Scholar PubMed

3. Alexandraki KI, Grossman AB. Is urinary free cortisol of value in the diagnosis of Cushing’s syndrome? Curr Opin Endocrinol Diabetes Obes 2011;18:259–63.10.1097/MED.0b013e3283487193Search in Google Scholar PubMed

4. Quinkler M, Stewart PM. Hypertension and the cortisol-cortisone shuttle. J Clin Endocrinol Metab 2003;88:2384–92.10.1210/jc.2003-030138Search in Google Scholar PubMed

5. White PC. 11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess. Am J Med Sci 2001;322:308–15.10.1097/00000441-200112000-00003Search in Google Scholar PubMed

6. Gatti R, Antonelli G, Prearo M, Spinella P, Cappellin E, De Palo EF. Cortisol assays and diagnostic laboratory procedures in human biological fluids. Clin Biochem 2009;42:1205–17.10.1016/j.clinbiochem.2009.04.011Search in Google Scholar PubMed

7. Horie H, Kidowaki T, Koyama Y, Endo T, Homma K, Kambegawa A, et al. Specificity assessment of immunoassay kits for determination of urinary free cortisol concentrations. Clin Chim Acta 2007;378:66–70.10.1016/j.cca.2006.10.018Search in Google Scholar PubMed

8. Gray G, Shakerdi L, Wallace AM. Poor specificity and recovery of urinary free cortisol as determined by the Bayer ADVIA Centaur extraction method. Ann Clin Biochem 2003;40:563–5.10.1258/000456303322326506Search in Google Scholar PubMed

9. Kennedy DM, Selby C, Lawson N. Measurement of urinary free cortisol using the Acs:180 serum cortisol chemiluminescent immunoassay. Ann Clin Biochem 2000;37:520–8.10.1177/000456320003700414Search in Google Scholar PubMed

10. Turpeinen U, Markkanen H, Välimäki M, Stenman UH. Determination of urinary free cortisol by HPLC. Clin Chem 1997;43:1386–91.10.1093/clinchem/43.8.1386Search in Google Scholar

11. Hay M, Mormède P. Improved determination of urinary cortisol and cortisone, or corticosterone and 11-dehydrocorticosterone by high-performance liquid chromatography with ultraviolet absorbance detection. J Chromatogr B Biomed Sci Appl 1997;702:33–9.10.1016/S0378-4347(97)00361-7Search in Google Scholar

12. Lin CL, Wu TJ, Machacek DA, Jiang NS, Kao PC. Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 1997;82:151–5.10.1210/jc.82.1.151Search in Google Scholar

13. Gatti R, Cappellin E, Zecchin B, Antonelli G, Spinella P, Mantero F, et al. Urinary high performance reverse phase chromatography cortisol and cortisone analyses before and at the end of a race in elite cyclists. J Chromatogr B Analyt Technol Biomed Life Sci 2005;829:154–9.10.1016/j.jchromb.2005.11.018Search in Google Scholar

14. Findling JW, Pinkstaff SM, Shaker JL, Raff H, Nelson JC. Pseudohypercortisoluria-spurious elevation of urinary cortisol due to carbamazepine. The Endocrinologist 1998;8:51–4.10.1097/00019616-199803000-00001Search in Google Scholar

15. Vogeser M, Parhofer KG. Liquid chromatography tandem-mass spectrometry (LC-MS/MS) – technique and applications in endocrinology. Exp Clin Endocrinol Diabetes 2007;115:559–70.10.1055/s-2007-981458Search in Google Scholar PubMed

16. Kushnir MM, Rockwood AL, Bergquist J. Liquid chromatography-tandem mass spectrometry applications in endocrinology. Mass Spectrom Rev 2010;29:480–502.10.1002/mas.20264Search in Google Scholar PubMed

17. Kushnir MM, Rockwood AL, Roberts WL, Yue B, Bergquist J, Meikle AW. Liquid chromatography tandem mass spectrometry for analysis of steroids in clinical laboratories. Clin Biochem 2011;44:77–88.10.1016/j.clinbiochem.2010.07.008Search in Google Scholar PubMed

18. van den Ouweland JM, Kema IP. The role of liquid chromatography–tandem mass spectrometry in the clinical laboratory. J Chromatogr B Analyt Technol Biomed Life Sci 2012; 883–884:18–32.10.1016/j.jchromb.2011.11.044Search in Google Scholar PubMed

19. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, et al. The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008;93:1526–40.10.1210/jc.2008-0125Search in Google Scholar PubMed PubMed Central

20. Van Eeckhaut A, Lanckmans K, Sarre S, Smolders I, Michotte Y. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:2198–207.10.1016/j.jchromb.2009.01.003Search in Google Scholar PubMed

21. Kushnir MM, Neilson R, Roberts WL, Rockwood AL. Cortisol and cortisone analysis in serum and plasma by atmospheric pressure photoionization tandem mass spectrometry. Clin Biochem 2004;37:357–62.10.1016/j.clinbiochem.2004.01.005Search in Google Scholar PubMed

22. Taylor RL, Machacek D, Singh RJ. Validation of a high- throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol and cortisone. Clin Chem 2002;48:1511–19.10.1093/clinchem/48.9.1511Search in Google Scholar

23. Remer T, Maser-Gluth C. Simultaneous measurements of urinary free cortisol and cortisone for the assessment of functional glucocorticoid activity. Clin Chem 2007;53: 1870–1.10.1373/clinchem.2007.092031Search in Google Scholar PubMed

24. Remer T, Maser-Gluth C, Boye KR, Hartmann MF, Heinze E, Wudy SA. Exaggerated adrenarche and altered cortisol metabolism in Type 1 diabetic children. Steroids 2006;71:591–8.10.1016/j.steroids.2006.02.005Search in Google Scholar PubMed

25. Persichilli S, Gervasoni J, Iavarone F, Zuppi C. A simple liquid chromatography-tandem mass spectrometry method for urinary free cortisol analysis: suitable for routine purpose. Clin Chem Lab Med 2010;48:1433–7.10.1515/CCLM.2010.282Search in Google Scholar PubMed

26. Fong BM, Tam S, Leung KS. Improved liquid chromatography-tandem mass spectrometry method in clinical utility for the diagnosis of Cushing’s syndrome. Anal Bioanal Chem 2010;396:783–90.10.1007/s00216-009-3247-1Search in Google Scholar PubMed

27. McWhinney BC, Briscoe SE, Ungerer JP, Pretorius CJ. Measurement of cortisol, cortisone, prednisolone, dexamethasone and 11-deoxycortisol with ultra high performance liquid chromatography-tandem mass spectrometry: application for plasma, plasma ultrafiltrate, urine and saliva in a routine laboratory. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:2863–9.10.1016/j.jchromb.2010.08.044Search in Google Scholar PubMed

28. Saba A, Raffaelli A, Cupisti A, Petri A, Marcocci C, Salvadori P. Recent advances in the assessment of the ratios of cortisol to cortisone and of some of their metabolites in urine by LC-MS-MS. J Mass Spectrom 2009; 44:541–8.10.1002/jms.1530Search in Google Scholar PubMed

29. Plebani M. Harmonization in laboratory medicine: the complete picture. Clin Chem Lab Med 2013;51:741–51.10.1515/cclm-2013-0075Search in Google Scholar PubMed

Received: 2013-6-25
Accepted: 2013-9-3
Published Online: 2013-10-12
Published in Print: 2014-2-1

©2014 by Walter de Gruyter Berlin Boston

Downloaded on 23.5.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2013-0471/html
Scroll to top button